2024 Q2 Form 10-Q Financial Statement

#000140658724000074 Filed on April 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $318.4M $333.8M
YoY Change -13.69% 10.71%
Cost Of Revenue $246.9M $250.5M
YoY Change -13.03% 2.0%
Gross Profit $71.50M $83.30M
YoY Change -15.88% 49.02%
Gross Profit Margin 22.46% 24.96%
Selling, General & Admin $29.30M $29.20M
YoY Change 10.98% 32.73%
% of Gross Profit 40.98% 35.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $900.0K $600.0K
YoY Change 12.5% -25.0%
% of Gross Profit 1.26% 0.72%
Operating Expenses $29.30M $29.20M
YoY Change 10.98% 32.73%
Operating Profit $42.20M $54.10M
YoY Change -27.99% 59.59%
Interest Expense $4.400M $5.000M
YoY Change 15.79% 150.0%
% of Operating Profit 10.43% 9.24%
Other Income/Expense, Net
YoY Change
Pretax Income $51.60M $58.90M
YoY Change -17.31% 64.07%
Income Tax $12.90M $13.90M
% Of Pretax Income 25.0% 23.6%
Net Earnings $38.70M $45.00M
YoY Change -17.31% 67.29%
Net Earnings / Revenue 12.15% 13.48%
Basic Earnings Per Share $0.76 $0.90
Diluted Earnings Per Share $0.76 $0.89
COMMON SHARES
Basic Shares Outstanding 50.60M shares 49.91M shares
Diluted Shares Outstanding 51.06M shares 50.63M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $359.2M $416.2M
YoY Change -10.42% 45.17%
Cash & Equivalents $359.2M $416.2M
Short-Term Investments
Other Short-Term Assets $13.00M $9.900M
YoY Change -28.57% -41.07%
Inventory
Prepaid Expenses
Receivables $33.00M $28.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $359.2M $454.6M
YoY Change -19.06% 58.56%
LONG-TERM ASSETS
Property, Plant & Equipment $6.500M $2.130B
YoY Change -99.66% 6.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $300.0K $500.0K
YoY Change -40.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $2.316B $2.144B
YoY Change 19.89% 4.61%
TOTAL ASSETS
Total Short-Term Assets $359.2M $454.6M
Total Long-Term Assets $2.316B $2.144B
Total Assets $2.675B $2.599B
YoY Change 12.61% 11.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.90M $61.70M
YoY Change 3.35% -8.86%
Accrued Expenses $168.5M $141.4M
YoY Change 39.83% -3.94%
Deferred Revenue $5.500M $5.700M
YoY Change -26.67% -50.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $403.2M $355.8M
YoY Change 24.98% 3.13%
LONG-TERM LIABILITIES
Long-Term Debt $706.1M $705.7M
YoY Change -0.16% -0.16%
Other Long-Term Liabilities $13.10M $13.50M
YoY Change -12.67% -26.63%
Total Long-Term Liabilities $706.1M $719.2M
YoY Change -2.23% 1.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $403.2M $355.8M
Total Long-Term Liabilities $706.1M $719.2M
Total Liabilities $1.162B $1.127B
YoY Change 7.61% 3.52%
SHAREHOLDERS EQUITY
Retained Earnings $796.7M $758.0M
YoY Change 32.25% 36.43%
Common Stock $715.2M $713.9M
YoY Change 3.19% 3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.512B $1.472B
YoY Change
Total Liabilities & Shareholders Equity $2.675B $2.599B
YoY Change 12.61% 11.23%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $38.70M $45.00M
YoY Change -17.31% 67.29%
Depreciation, Depletion And Amortization $900.0K $600.0K
YoY Change 12.5% -25.0%
Cash From Operating Activities -$61.70M -$59.20M
YoY Change -153.7% -183.26%
INVESTING ACTIVITIES
Capital Expenditures $600.0K $600.0K
YoY Change 20.0% 200.0%
Acquisitions
YoY Change
Other Investing Activities $5.100M $0.00
YoY Change
Cash From Investing Activities $4.500M -$600.0K
YoY Change -1000.0% 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0K 17.10M
YoY Change -300.0% -2950.0%
NET CHANGE
Cash From Operating Activities -61.70M -59.20M
Cash From Investing Activities 4.500M -600.0K
Cash From Financing Activities 200.0K 17.10M
Net Change In Cash -57.00M -42.70M
YoY Change -149.87% -160.74%
FREE CASH FLOW
Cash From Operating Activities -$61.70M -$59.20M
Capital Expenditures $600.0K $600.0K
Free Cash Flow -$62.30M -$59.80M
YoY Change -154.46% -184.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1600000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
11300000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2600000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1800000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1472900000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
22700000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1125800000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1100800000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49903713 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49903713 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
50600000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
1000000.0 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
1000000.0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1472900000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1369900000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2598700000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2470700000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
695000000.0 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
49900000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
663300000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
644200000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
758000000.0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
674800000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1471900000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1368900000 usd
us-gaap Revenues
Revenues
639700000 usd
us-gaap Revenues
Revenues
518200000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
483700000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
414800000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57200000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44900000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
3700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
110100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26900000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
45000000.0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
26900000 usd
us-gaap Profit Loss
ProfitLoss
83200000 usd
us-gaap Profit Loss
ProfitLoss
47700000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49900000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1369900000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
38200000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
200000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
900000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1408800000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
45000000.0 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19700000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1199300000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
20800000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
600000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1220600000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
26900000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
700000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1248800000 usd
us-gaap Profit Loss
ProfitLoss
83200000 usd
us-gaap Profit Loss
ProfitLoss
47700000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-100000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1200000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2700000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2500000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
400000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1600000 usd
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
300000 usd
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
316100000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9600000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2100000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000000.0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12100000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26500000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3200000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-23200000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
23100000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215900000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21300000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
800000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
300000 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
1600000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-800000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19700000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2800000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16900000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-700000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-199800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21900000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
416200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286700000 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
2115900000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1790300000 usd
us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
350000000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
450300000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
19400000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19400000 usd
CY2024Q1 us-gaap Loss On Contract Termination
LossOnContractTermination
200000 usd
us-gaap Loss On Contract Termination
LossOnContractTermination
400000 usd
CY2023Q1 us-gaap Loss On Contract Termination
LossOnContractTermination
900000 usd
us-gaap Loss On Contract Termination
LossOnContractTermination
3300000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
10100000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
62200000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1700000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000.0 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 usd
CY2024Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
6200000 usd
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
41100000 usd
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
6600000 usd
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
44400000 usd
CY2024Q1 us-gaap Revenues
Revenues
333800000 usd
CY2023Q1 us-gaap Revenues
Revenues
301500000 usd
us-gaap Revenues
Revenues
639700000 usd
us-gaap Revenues
Revenues
518200000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1700000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
7500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14300000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
60500000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
55700000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
58500000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
52500000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
8200000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
8200000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
16300000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
16400000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
6500000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
5100000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
12600000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
58800000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
62200000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
58800000 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
28500000 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
25700000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8200000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7600000 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
9900000 usd
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
15700000 usd
CY2024Q1 us-gaap Deposits Assets
DepositsAssets
11700000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
7000000.0 usd
CY2024Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
1700000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
2000000.0 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
60000000.0 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
58000000.0 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
10900000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
11200000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
4700000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
7900000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8800000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8100000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7100000 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7000000.0 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5700000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10000000.0 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
4100000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
4100000 usd
CY2024Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
8200000 usd
CY2023Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
4400000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2600000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4800000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
3700000 usd
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
3700000 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
55800000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
61200000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
705700000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
695000000.0 usd
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
410000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 usd
CY2024Q1 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 usd
CY2024Q1 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
28000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
382000000 usd
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 usd
CY2024Q1 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
45000000.0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26900000 usd
us-gaap Net Income Loss
NetIncomeLoss
83200000 usd
us-gaap Net Income Loss
NetIncomeLoss
47700000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50147639 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49943373 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50106735 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49916927 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
479318 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
67166 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
437784 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
37854 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50626957 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50010539 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50544519 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49954781 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
CY2024Q1 ecd Insider Trd Policies Proc Adopted Flag
InsiderTrdPoliciesProcAdoptedFlag
false
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16100000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252
CY2024Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
50000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
800000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
50800000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
49800000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
900000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
50700000 usd
CY2021Q4 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
750000000 usd
CY2021Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
300000000 usd
for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
546174 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19700000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000 usd
CY2024Q1 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
728100000 usd
CY2024Q1 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
278100000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
154034 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.19
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1800000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2700000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1900000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2500000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
28000000 usd
CY2024Q1 us-gaap Special Assessment Bond
SpecialAssessmentBond
660900000 usd
CY2024Q1 us-gaap Deposits Assets
DepositsAssets
11700000 usd
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
752000000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
3100000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
900000 usd
CY2024Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
57400 lot
CY2023Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
52400 lot
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
416200000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
705700000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
616000000.0 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
695000000.0 usd

Files In Submission

Name View Source Status
0001406587-24-000074-index-headers.html Edgar Link pending
0001406587-24-000074-index.html Edgar Link pending
0001406587-24-000074.txt Edgar Link pending
0001406587-24-000074-xbrl.zip Edgar Link pending
a3312024exhibit311.htm Edgar Link pending
a3312024exhibit312.htm Edgar Link pending
a3312024exhibit321.htm Edgar Link pending
a3312024exhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
for-20240331.htm Edgar Link pending
for-20240331.xsd Edgar Link pending
for-20240331_g1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
for-20240331_cal.xml Edgar Link unprocessable
for-20240331_def.xml Edgar Link unprocessable
for-20240331_lab.xml Edgar Link unprocessable
for-20240331_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
for-20240331_pre.xml Edgar Link unprocessable